Clinical Trials Logo

Clinical Trial Summary

Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides a quantitative estimation of proximal tubule reabsorption. The investigators hypothesized that endogenous lithium reabsorption is impaired in the early stages of critical illness. Investigators would like to study 10 ICU patients with AKI diagnosed, 10 patients without AKI, and 10 healthy controls.


Clinical Trial Description

Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05982340
Study type Observational
Source University Hospital of North Norway
Contact Lars Marius Ytrebø
Phone 90788058
Email lars.marius.ytrebo@unn.no
Status Recruiting
Phase
Start date August 1, 2023
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05114057 - Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI N/A
Active, not recruiting NCT05507437 - Pharmacokinetics and Safety of TIN816 in Patients With Sepsis-associated Acute Kidney Injury Phase 2
Terminated NCT04411472 - (Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI Phase 3
Recruiting NCT05939245 - Comparison of Plasma Neutrophil Gelatinase-Associated Lipocalin (pNGAL) Level in De-resuscitation With Furosemide Group and Control Group N/A
Recruiting NCT06295393 - Renin Angiotensin Aldosterone System In Septic Kids
Completed NCT04633746 - Plasma Endostatin Predicts Outcome of Septic AKI
Recruiting NCT05996835 - Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI) Phase 2
Recruiting NCT05575024 - Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane
Completed NCT05060679 - Presepsin:Gelsolin Ratio in Sepsis-related Organ Dysfunction
Completed NCT04968262 - Urinary Actin, as a Potential Marker of Sepsis-related Acute Kidney Injury
Not yet recruiting NCT05559086 - N/LP Ratio as Predictor of Mortality in Septic AKI Patients